YOLFTbeta
Allurion Technologies, Inc.

Allurion Technologies, Inc.

ALUR · NYSE · Healthcare / Medical Devices

0.002USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.002
Open0.002
Day Range0.002 – 0.002
52-Week Range0.23 – 8.52
Volume1.30K
Market Cap1.11M
P/E (TTM)0.00
Forward P/E1.00
EPS-59.40
Dividend Yield0.00%
Beta-0.19
50-Day Avg2.70
200-Day Avg1.82

About

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Ojas A. Buch
  • Employees38
  • Headquarters11 Huron Drive, Natick, MA, United States, 01760, USA
  • Websitehttps://www.allurion.com

Leadership

  • Mr. Ojas A. BuchChief Operating Officer · b. 1974
  • Mr. Brendan Michael Gibbons J.D.Chief Legal & People Officer and Secretary · b. 1976
  • Dr. Samuel G. LevyCo-Founder · b. 1983
  • Dr. Ram Chuttani M.D.MD & Founding Partner · b. 1961
  • Ms. Alexandra van der StapVice President of Global Marketing
  • Mr. Laurent LaffineurVice President of International Sales & Marketing

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-38.24M64.21M53.47M32.11M15.23M
Growth (%)--+67.91%-16.73%-39.94%-52.57%
Cost of Revenue-9.05M13.48M11.97M10.61M5.66M
Gross Profit-29.19M50.73M41.50M21.50M9.57M
Gross Margin-76.33%79.00%77.61%66.97%62.84%
Operating Expense-41.69M82.74M120.58M71.70M39.73M
Operating Income-5.17K-12.50M-32.01M-79.08M-50.20M-30.16M
Operating Margin--32.69%-49.85%-147.90%-156.33%-198.01%
EBITDA201.13K-8.01M-32.28M-69.03M-22.17M-27.70M
EBITDA Margin--20.95%-50.27%-129.11%-69.04%-181.86%
Net Income-5.17K-12.39M-37.74M-80.61M-26.15M-28.75M
Net Income Margin--32.39%-58.78%-150.76%-81.43%-188.80%
R&D-5.73M16.97M27.69M17.37M7.57M
R&D as % of Total Revenue-14.98%26.42%51.80%54.09%49.71%
Interest Expense-3.67M4.43M10.57M2.26M0
Interest Expense % of Total Revenue-9.59%6.89%19.76%7.05%0.00%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets329.96K39.35M51.37M71.71M32.81M15.77M
Total Liabilities310.13K73.64M83.68M142.20M110.79M92.96M
Total Equity19.83K-34.28M-32.31M-70.49M-77.98M-77.19M
Cash47.09K25.84M7.68M38.04M15.38M5.41M
Total Debt170.00K26.14M59.53M41.86M37.92M29.04M
Net Debt122.91K300.00K51.85M3.82M22.54M23.63M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-35-14.33M-46.98M-63.98M-42.30M-28.95M
Investing Cash Flow--912.00K-1.55M-1.61M-611.00K-
Financing Cash Flow47.13K28.95M30.54M95.99M20.21M18.97M
Capital Expenditure5912.00K1.55M1.61M611.00K0
Free Cash Flow-40-15.24M-48.53M-65.59M-42.91M-28.95M
Dividends Paid--132.00K---
FCF to OCF114.29%106.36%103.30%102.51%101.44%100.00%
Dividend Paid to FCF---0.27%---

Earnings

Report DateMay 24, 2021Aug 16, 2021Nov 19, 2021Mar 31, 2022May 13, 2022Aug 15, 2022Nov 21, 2022Dec 31, 2022Apr 4, 2023Jun 30, 2023Nov 29, 2023Mar 26, 2024May 14, 2024Aug 13, 2024Nov 13, 2024Mar 27, 2025May 15, 2025Aug 19, 2025Nov 12, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate0.000.000.000.000.000.000.00-0.00---0.51-0.30-0.24-0.18-0.17-0.19-0.13-0.10-9.45-5.10
EPS Actual-0.05-0.100.180.020.120.090.080.320.02-73.97-13.56-0.400.11-0.05-0.18-7.940.20-1.28-1.53-5.44-6.90
Surprise-----------20.86%136.67%79.17%-1.00%-4570.59%205.26%-884.62%-1430.00%42.44%-35.29%
Timing-----------After-hoursPre-marketPre-marketPre-market------

Key Statistics & Ratios

Market Cap1.11M
Enterprise Value25.54M
Trailing P/E0.00
Forward P/E1.00
Price / Sales0.09
Price / Book0.00
EPS-59.40
Book Value-77.94
Revenue (TTM)12.60M
Gross Profit (TTM)6.64M
EBITDA-27.05M
Profit Margin-264.74%
Operating Margin-126.60%
Return on Equity0.00%
Return on Assets-66.80%
Shares Outstanding1.00M
Shares Float968.70K
Beta-0.19
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 82.50
  • Strong Buy
    2
  • Buy
    1
  • Hold
    1

Stock Splits

  • Jan 3, 20251:25